Q4 2021 Redhill Biopharma Ltd Earnings Call Transcript
Good day, and welcome to the RedHill Biopharma's Fourth Quarter and Full Year 2021 Financial Results Conference Call. (Operator Instructions) At this time, I would like to introduce to the conference call RedHill's CEO, Dror Ben-Asher; Guy Goldberg, Chief Business Officer; Gilead Raday, Chief Operating Officer; Rob Jackson, Senior VP, Sales and Marketing; Rick Scruggs, Chief Commercial Officer; and Micha Ben-Chorin, Chief Financial Officer. We have additional senior management team members available to answer questions during the Q&A session, including Dr. June Almenoff, Chief Medical Officer; and Dr. Mark Levitt, Chief Scientific Officer.
Before we begin, we will read from RedHill's safe harbor statement. Please go ahead.
Thank you, Sharon. This conference call may contain projections or other forward-looking statements regarding future events or the future performance of RedHill, including statements with respect to the business financial results, promotion
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
